These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2013-003045-42||An Open-labelled, Randomized Phase II Multicentre Study to Investigate Efficacy of Autologous Lymphoid Effector Cells Specific Against Tumour-Cells (ALECSAT) in Patients with Glioblastoma Multiforme M...||2015-06-12||due-trials|
|Reported results Terminated||2015-004058-17||An open-label, randomised, Phase II study to investigate the efficacy and safety of ALECSAT treatment as an add-on therapy to radiotherapy and temozolomide in patients with newly diagnosed glioblastom...||2020-02-24||due-trials|